Skip navigation

Watson Pharmaceuticals Inc.

Parsippany New Jersey
2011 Revenue (US$ Millions)$4,584
2010 Revenue (US$ Millions)$3,567
Revenue Growth (%)28.53%
Net Income (US$ Millions)$261
Common Shares Outstanding (Millions)$127
Earnings Per Share (US$)$2.06
Earnings Per Share Growth (%)39.19%
Price To Earnings Ratio34.33
Total Equity (US$ Millions)$3,564
Profit Growth (%)41.49
Profit Margin (%)5.69%
Return On Equity (%)7.95%
Long Term Debt (US$ Millions)$665
Debt To Equity Ratio (%)0.19%
Market Capitalization (US$ Millions)$7,675
Total Assets (US$ Millions)$6,698
Return on Assets (%)4.48
Current Assets (US$ Millions)$2,570
Inventories (US$ Millions)$889
Current Liabilities (US$ Millions)$1,840
Cost of Goods Sold (US$ Millions)$2,565
Asset Turnover0.68
Inventory Turnover3.37